Loading...
XOSLCARA
Market cap131mUSD
Dec 04, Last price  
21.10NOK
Name

Carasent ASA

Chart & Performance

D1W1MN
XOSL:CARA chart
P/E
—
P/S
6.25
EPS
—
Div Yield, %
8.72%
Shrs. gr., 5y
13.85%
Rev. gr., 5y
59.06%
Revenues
244m
+24.95%
37,626,00055,074,000133,328,000210,380,000234,035,000250,429,000227,160,696242,774,971239,405,900254,181,307292,382,124302,531,783193,758,719023,965,00047,927,00070,576,000137,125,000195,259,000243,984,000
Net income
-46m
L
-47,558,000-42,456,000-37,226,000-138,521,000-57,573,000-20,429,000-18,283,3794,196,0667,062,6974,749,745060,232,094107,987,59320,307,113-7,036,0003,212,000-38,131,000-148,00031,170,000-46,445,000
CFO
-4m
L
-28,801,000-27,381,000-9,430,000-23,211,000-11,714,00010,643,0007,195,77322,162,15432,287,41429,076,22524,081,41400089,00012,045,00018,761,00032,480,00033,612,000-4,467,000
Dividend
Nov 15, 20231.84 NOK/sh
Earnings
Feb 13, 2025

Profile

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company develops Webdoc, a cloud based EMR-system; and Vårdrummet, a digital platform for interactive health care that enables healthcare providers to communicate with their patients through digital services, such as video, chat, and other channels. It also provides Ad Voca, Ad Opus, and Ad Curis. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
URL
https://carasent.com/
IPO date
Apr 08, 2002
Employees
166
Domiciled in
NO
Incorporated in
NO

Valuation

Title
NOK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
243,984
24.95%
195,259
42.39%
137,125
94.29%
Cost of revenue
104,002
107,989
67,959
Unusual Expense (Income)
NOPBT
139,982
87,270
69,166
NOPBT Margin
57.37%
44.69%
50.44%
Operating Taxes
(3,632)
2,704
3,882
Tax Rate
3.10%
5.61%
NOPAT
143,614
84,566
65,284
Net income
(46,445)
-249.01%
31,170
-21,160.81%
(148)
-99.61%
Dividends
(133,078)
Dividend yield
15.48%
Proceeds from repurchase of equity
(115,932)
(1,294)
790,758
BB yield
13.48%
0.10%
-31.42%
Debt
Debt current
12,535
10,033
5,703
Long-term debt
87,805
66,140
26,971
Deferred revenue
Other long-term liabilities
1,000
8,516
(2)
Net debt
(273,544)
(618,659)
(850,097)
Cash flow
Cash from operating activities
(4,467)
33,612
32,480
CAPEX
(69,203)
(91,562)
(38,227)
Cash from investing activities
(55,526)
(209,500)
(125,124)
Cash from financing activities
(263,278)
(10,195)
756,562
FCF
132,139
60,660
66,281
Balance
Cash
373,884
694,832
882,772
Long term investments
(1,000)
Excess cash
361,685
685,069
875,915
Stockholders' equity
59,927
100,786
68,279
Invested Capital
945,650
1,173,215
1,119,331
ROIC
13.56%
7.38%
8.51%
ROCE
13.78%
6.78%
5.78%
EV
Common stock shares outstanding
77,736
79,923
67,120
Price
11.06
-34.86%
16.98
-54.72%
37.50
-0.27%
Market cap
859,765
-36.65%
1,357,094
-46.08%
2,517,009
49.14%
EV
586,221
748,996
1,669,472
EBITDA
190,877
121,351
92,502
EV/EBITDA
3.07
6.17
18.05
Interest
2,093
1,274
646
Interest/NOPBT
1.50%
1.46%
0.93%